IBDEI1MF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28771,1,5,0)
 ;;=5^Hx-Intrathoracic Ca
 ;;^UTILITY(U,$J,358.3,28771,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,28772,0)
 ;;=V10.87^^163^1825^25
 ;;^UTILITY(U,$J,358.3,28772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28772,1,2,0)
 ;;=2^V10.87
 ;;^UTILITY(U,$J,358.3,28772,1,5,0)
 ;;=5^Hx-Thyroid Ca
 ;;^UTILITY(U,$J,358.3,28772,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,28773,0)
 ;;=V10.46^^163^1825^20
 ;;^UTILITY(U,$J,358.3,28773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28773,1,2,0)
 ;;=2^V10.46
 ;;^UTILITY(U,$J,358.3,28773,1,5,0)
 ;;=5^Hx-Prostate Ca
 ;;^UTILITY(U,$J,358.3,28773,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,28774,0)
 ;;=V10.47^^163^1825^24
 ;;^UTILITY(U,$J,358.3,28774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28774,1,2,0)
 ;;=2^V10.47
 ;;^UTILITY(U,$J,358.3,28774,1,5,0)
 ;;=5^Hx-Testicular Ca
 ;;^UTILITY(U,$J,358.3,28774,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,28775,0)
 ;;=V10.3^^163^1825^5
 ;;^UTILITY(U,$J,358.3,28775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28775,1,2,0)
 ;;=2^V10.3
 ;;^UTILITY(U,$J,358.3,28775,1,5,0)
 ;;=5^Hx-Breast Ca
 ;;^UTILITY(U,$J,358.3,28775,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,28776,0)
 ;;=V10.81^^163^1825^3
 ;;^UTILITY(U,$J,358.3,28776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28776,1,2,0)
 ;;=2^V10.81
 ;;^UTILITY(U,$J,358.3,28776,1,5,0)
 ;;=5^Hx-Bone Ca
 ;;^UTILITY(U,$J,358.3,28776,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,28777,0)
 ;;=V10.82^^163^1825^16
 ;;^UTILITY(U,$J,358.3,28777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28777,1,2,0)
 ;;=2^V10.82
 ;;^UTILITY(U,$J,358.3,28777,1,5,0)
 ;;=5^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,28777,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,28778,0)
 ;;=V10.83^^163^1825^22
 ;;^UTILITY(U,$J,358.3,28778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28778,1,2,0)
 ;;=2^V10.83
 ;;^UTILITY(U,$J,358.3,28778,1,5,0)
 ;;=5^Hx-Skin Ca
 ;;^UTILITY(U,$J,358.3,28778,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,28779,0)
 ;;=V10.88^^163^1825^7
 ;;^UTILITY(U,$J,358.3,28779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28779,1,2,0)
 ;;=2^V10.88
 ;;^UTILITY(U,$J,358.3,28779,1,5,0)
 ;;=5^Hx-Endocrine Malignancy
 ;;^UTILITY(U,$J,358.3,28779,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,28780,0)
 ;;=V10.85^^163^1825^4
 ;;^UTILITY(U,$J,358.3,28780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28780,1,2,0)
 ;;=2^V10.85
 ;;^UTILITY(U,$J,358.3,28780,1,5,0)
 ;;=5^Hx-Brain Ca
 ;;^UTILITY(U,$J,358.3,28780,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,28781,0)
 ;;=V10.86^^163^1825^17
 ;;^UTILITY(U,$J,358.3,28781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28781,1,2,0)
 ;;=2^V10.86
 ;;^UTILITY(U,$J,358.3,28781,1,5,0)
 ;;=5^Hx-Nervous Syst Ca
 ;;^UTILITY(U,$J,358.3,28781,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,28782,0)
 ;;=V10.91^^163^1825^1
 ;;^UTILITY(U,$J,358.3,28782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28782,1,2,0)
 ;;=2^V10.91
 ;;^UTILITY(U,$J,358.3,28782,1,5,0)
 ;;=5^HX Malig Neuroendo Tu
 ;;^UTILITY(U,$J,358.3,28782,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,28783,0)
 ;;=V10.51^^163^1825^2
 ;;^UTILITY(U,$J,358.3,28783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28783,1,2,0)
 ;;=2^V10.51
 ;;^UTILITY(U,$J,358.3,28783,1,5,0)
 ;;=5^Hx-Bladder
 ;;^UTILITY(U,$J,358.3,28783,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,28784,0)
 ;;=V10.52^^163^1825^11
 ;;^UTILITY(U,$J,358.3,28784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28784,1,2,0)
 ;;=2^V10.52
 ;;^UTILITY(U,$J,358.3,28784,1,5,0)
 ;;=5^Hx-Kidney
 ;;^UTILITY(U,$J,358.3,28784,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,28785,0)
 ;;=99212^^164^1826^6
 ;;^UTILITY(U,$J,358.3,28785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28785,1,2,0)
 ;;=2^99212
 ;;
 ;;$END ROU IBDEI1MF
